Claude P Genain Selected Research

Epitopes

11/2011	Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosis.
4/2006	Restrictive and diversifying elements of the anti-myelin/oligodendrocyte glycoprotein antibody response in primate experimental allergic encephalomyelitis.
2/2006	Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.
8/2004	Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claude P Genain Research Topics

Disease

11	Multiple Sclerosis 11/2011 - 03/2002
5	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 04/2006 - 06/2002
5	Demyelinating Diseases (Demyelinating Disease) 02/2006 - 03/2002
2	Inflammation (Inflammations) 02/2006 - 01/2004
2	Disease Progression 09/2003 - 09/2002
1	Neuromyelitis Optica (Devic's Disease) 07/2011
1	Brain Injuries (Brain Injury) 01/2004
1	Encephalitis (Encephalitis, Rasmussen) 01/2004
1	Encephalomyelitis (Myeloencephalitis) 09/2003
1	Autoimmune Diseases (Autoimmune Disease) 09/2003
1	Relapsing-Remitting Multiple Sclerosis 09/2002
1	Central Nervous System Diseases (CNS Diseases) 03/2002

Drug/Important Bio-Agent (IBA)

7	Myelin-Oligodendrocyte GlycoproteinIBA 11/2011 - 03/2002
4	EpitopesIBA 11/2011 - 08/2004
4	AntibodiesIBA 07/2011 - 08/2004
4	AutoantibodiesIBA 04/2006 - 03/2002
3	Immunoglobulin G (IgG)IBA 02/2006 - 06/2002
2	AutoantigensIBA 11/2011 - 06/2002
2	Proteins (Proteins, Gene)FDA Link 09/2003 - 03/2002
1	Rituximab (Mabthera)FDA Link 07/2011
1	galactocerebrosideIBA 08/2005
1	GlycolipidsIBA 08/2005
1	Biomarkers (Surrogate Marker)IBA 08/2005
1	Poly Adenosine Diphosphate RiboseIBA 07/2005
1	Poly (ADP-Ribose) Polymerase-1IBA 07/2005
1	Nerve Growth Factor (NGF)IBA 01/2004
1	Nerve Growth Factors (Neurotrophins)IBA 01/2004
1	CytokinesIBA 01/2004
1	DNA VaccinesIBA 09/2003
1	ProteomeIBA 09/2003
1	Interferon-betaIBA 09/2002
1	Glatiramer Acetate (Copaxone)FDA Link 09/2002
1	AntigensIBA 06/2002
1	Myelin ProteinsIBA 06/2002
1	Immunoglobulins (Immunoglobulin)IBA 03/2002
1	Membrane Proteins (Integral Membrane Proteins)IBA 03/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 09/2002
1	Therapeutics 03/2002